Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Lett Appl Microbiol ; 37(6): 448-51, 2003.
Article in English | MEDLINE | ID: mdl-14633097

ABSTRACT

AIMS: The objective of this study was to evaluate the inhibitory activity of several natural organic compounds alone or in combination with nisin against Escherichia coli and Salmonella Typhimurium. METHODS AND RESULTS: The minimum inhibitory concentration (MIC) of five natural organic compounds were determined, and the effect of their combinations with nisin was evaluated by the checkerboard assay using the Bioscreen C. As expected, nisin by itself showed no inhibition against either of the Gram-negative bacteria. Thymol was found to be the most effective with the lowest MIC values of 1.0 and 1.2 mmol 1-1 against Salm. Typhimurium and E. coli, respectively. After thymol, the antimicrobial order of the natural organic compounds was carvacrol > eugenol > cinnamic acid > diacetyl. However, the combination of nisin with the natural organic compounds did not result in the enhancement of their antimicrobial activities. On the contrary, combination of nisin with diacetyl against Salm. Typhimurium resulted in an antagonism of diacetyl activity. CONCLUSIONS: While the individual natural organic compounds showed inhibitory activity against the two Gram-negatives, their combinations with nisin showed no improvement of antimicrobial activity. SIGNIFICANCE AND IMPACT OF THE STUDY: This study shows the potential of the natural organic compounds to control E. coli and Salm. Typhimurium.


Subject(s)
Anti-Bacterial Agents/pharmacology , Escherichia coli/drug effects , Salmonella typhimurium/drug effects , Cinnamates/pharmacology , Cymenes , Diacetyl/antagonists & inhibitors , Diacetyl/pharmacology , Drug Therapy, Combination/pharmacology , Escherichia coli/growth & development , Eugenol/pharmacology , In Vitro Techniques , Microbial Sensitivity Tests , Monoterpenes/pharmacology , Nisin/pharmacology , Salmonella typhimurium/growth & development , Thymol/pharmacology
2.
Eur J Pharmacol ; 296(3): 285-9, 1996 Feb 05.
Article in English | MEDLINE | ID: mdl-8904080

ABSTRACT

The effects of 2,3-butanedione monoxime (BDM) and 5-[1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydro-6-quinolyl]-6-me thy l-3,6-dihydro-2H-1,3,4-thiadiazin-2-one (EMD 53998) on cardiac muscle were studied in skinned muscle fibres from the right ventricle of the porcine heart. BDM decreases the Ca2+ sensitivity (pCa50 for 50% activation) and it exerts a dose-dependent inhibitory effect on force in troponin I (TnI)-depleted (unregulated) cardiac skinned muscle fibres (IC50 approximately 20 mM) thereby mimicking the effect of the TnI inhibitory peptide (cTnI 137-148, corresponding to the cardiac TnI inhibitory region) and that of inorganic phosphate (Pi). This inhibitory action can be antagonized by the calcium-sensitizing cardiotonic thiadiazinone derivative EMD 53998 that increases the IC50 to about 30 mM. In skinned fibres, BDM (10 mM) also increased the ratio of ATPase activity to isometric force (tension cost), whereas EMD 53998 (20 mu M) decreased it. We propose that BDM antagonizes EMD 53998 because both compounds affect the Pi release step of the crossbridge cycle in an antagonistic manner.


Subject(s)
Calcium/metabolism , Diacetyl/analogs & derivatives , Muscle Fibers, Skeletal/drug effects , Myocardial Contraction/drug effects , Quinolines/pharmacology , Thiadiazines/pharmacology , Adenosine Triphosphatases/metabolism , Animals , Diacetyl/antagonists & inhibitors , In Vitro Techniques , Muscle Fibers, Skeletal/physiology , Phosphates/metabolism , Swine
3.
Ann Pharm Fr ; 54(4): 182-91, 1996.
Article in French | MEDLINE | ID: mdl-8881105

ABSTRACT

Diacetyl, in deaerated solutions, is a major room temperature phosphorescent compound. Its phosphorescence quenching is proposed in order to quantify results on phenothiazine derivatives. It is established from the luminescent data on phenothiazines that diacetyl phosphorescence can be quenched quantitatively by these compounds. This detection mode is applied to liquid chromatography limitations as well as the mechanism of the quenching are discussed.


Subject(s)
Diacetyl/antagonists & inhibitors , Luminescent Proteins/antagonists & inhibitors , Phenothiazines/pharmacology , Chromatography, High Pressure Liquid , Structure-Activity Relationship
4.
Can J Physiol Pharmacol ; 63(10): 1267-70, 1985 Oct.
Article in English | MEDLINE | ID: mdl-2416416

ABSTRACT

Effects of a novel slow channel activator, Bay K-8644 (Bay K), were studied on slow action potential (APs) in young and old embryonic chick hearts, and on its antagonism of the effects of diacetyl monoxime (DAM). The slow APs of young hearts are mediated by slow Na+ channels, whereas those of old hearts are mediated by slow Ca2+ channels. In slow APs of old (13-18 days old) embryonic chick hearts superfused with a high (22 mM) K+ solution, Bay K (10-6 M) gradually increased the amplitude, maximum rate of rise (Vmax), and duration of the slow APs. The actions of Bay K persisted for a long time (greater than 30 min) after washout of the drug. DAM (10 mM) depressed the Vmax, duration and amplitude of the slow APs. Some of the changes in slow AP parameters produced by DAM, e.g., Vmax decrease, were antagonized by the addition of Bay K (10(-6) M). In 3-day-old embryonic chick hearts. Bay K potentiated the slow APs and DAM depressed them; Bay K antagonized these effects of DAM. Thus, the actions of Bay K and DAM are likely to be produced, respectively, via the activation and depression of slow Ca2+ channels in old embryonic chick hearts. In addition, the drugs seem to influence slow Na+ channels found in young embryonic chick hearts.


Subject(s)
Butanones/antagonists & inhibitors , Diacetyl/antagonists & inhibitors , Heart/physiology , Ion Channels/drug effects , Nifedipine/analogs & derivatives , 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester , Action Potentials/drug effects , Animals , Chick Embryo , Diacetyl/analogs & derivatives , Heart/drug effects , Heart/embryology , Nifedipine/pharmacology
5.
Eur J Biochem ; 148(1): 35-9, 1985 Apr 01.
Article in English | MEDLINE | ID: mdl-2858389

ABSTRACT

The H+-translocating adenosine-5'-triphosphatase (ATPase) purified from the yeast Schizosaccharomyces pombe is inactivated upon incubation with the arginine modifier 2,3-butanedione. The inactivation of the enzyme is maximal at pH values above 8.5. The modified enzyme is reactivated when incubated in the absence of borate after removal of 2,3-butanedione. The extent of inactivation is half maximal at 10 mM 2,3-butanedione for an incubation of 30 min at 30 degrees C at pH 7.0. Under the same conditions, the time-dependence of inactivation is biphasic in a semi-logarithmic plot with half-lives of 10.9 min and 65.9 min. Incubation with 2,3-butanedione lowering markedly the maximal rate of ATPase activity does not modify the Km for MgATP. These data suggest that two classes of arginyl residues play essential role in the plasma membrane ATPase activity. Magnesium adenosine 5'-triphosphate (MgATP) and magnesium adenosine 5'-diphosphate (MgADP), the specific substrate and product, protect partially against enzyme inactivation by 2,3-butanedione. Free ATP or MgGTP which are not enzyme substrates do not protect. Free magnesium, another effector of enzyme activity, exhibits partial protection at magnesium concentrations up to 0.5 mM, while increased inactivation is observed at higher Mg2+ concentrations. These protections indicate either the existence of at least one reactive arginyl in the substrate binding site or a general change of enzyme conformation induced by MgATP, MgADP or free magnesium.


Subject(s)
Arginine/analysis , Ascomycota/enzymology , Proton-Translocating ATPases/metabolism , Schizosaccharomyces/enzymology , Cell Membrane/enzymology , Chemical Phenomena , Chemistry , Diacetyl/antagonists & inhibitors , Diacetyl/pharmacology , Magnesium/pharmacology , Proton-Translocating ATPases/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...